QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

DoubleVerify Holdings Inc. (NYSE:DV) will replace Meridian Bioscience Inc. (NASD: VIVO) in the S&P SmallCap 600 effective p...

 meridian-bioscience-q4-eps-020-down-from-023-yoy-sales-6567m-down-from-7620m-yoy

Meridian Bioscience (NASDAQ:VIVO) reported quarterly earnings of $0.20 per share. This is a 13.04 percent decrease over earning...

 meridian-bioscience-as-of-october-11-obtained-merger-approval-for-all-relevant-antitrust-and-fdi-filings-except-for-filing-related-to-committee-on-foreign-investment-in-the-united-states

- Reuters 

 looking-into-meridian-biosciences-return-on-capital-employed

Meridian Bioscience (NASDAQ:VIVO) brought in sales totaling $67.77 million during Q3 according to data provided by Benzinga Pro...

 meridian-bioscience-q3-earnings-insights

  Meridian Bioscience (NASDAQ:VIVO) reported its Q3 earnings results on Friday, August 5, 2022 at 08:00 AM. Here's what i...

 meridian-bioscience-q3-eps-016-inline-sales-6780m-beat-6682m-estimate

Meridian Bioscience (NASDAQ:VIVO) reported quarterly earnings of $0.16 per share which met the analyst consensus estimate. This...

 earnings-scheduled-for-august-5-2022

  Companies Reporting Before The Bell • Reservoir Media (NASDAQ:RSVR) is projected to report quarterly loss at $0.05 per shar...

 preview-meridian-biosciences-earnings

Meridian Bioscience (NASDAQ:VIVO) is set to give its latest quarterly earnings report on Friday, 2022-08-05. Here's what in...

 meridian-bioscience-receives-re-authorization-from-fda-for-its-revogene-sars-cov-2-molecular-assay

Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading global provider of diagnostic testing solutions and life science raw materia...

 hc-wainwright--co-downgrades-meridian-bioscience-to-neutral-raises-price-target-to-34

HC Wainwright & Co. analyst Yi Chen downgrades Meridian Bioscience (NASDAQ:VIVO) from Buy to Neutral and raises the pric...

 cannabis-stock-gainers-and-losers-from-july-6-2022

GAINERS: Tilray Brands (NASDAQ:TLRY) shares closed up 8.02% at $3.50

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION